Navigation Links
Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec®
Date:12/12/2011

s in blast crisis, accelerated phase, and in the chronic phase after failure of interferon-alpha therapy.

DisclaimerThe foregoing release contains forward-looking statements that can be identified by terminology such as "should," "could," "look forward to," or similar expressions, or by express or implied discussions regarding potential new indications or labeling for Tasigna or regarding potential future revenues from Tasigna or Gleevec. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results with Tasigna or Gleevec to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that Tasigna will be submitted or approved for any additional indications or labeling in any market, or at any particular time. Nor can there be any guarantee that Tasigna or Gleevec will achieve any particular levels of revenue in the future. In particular, management's expectations regarding Tasigna or Gleevec could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data; the company's ability to obtain or maintain patent or other proprietary intellectual protection; unexpected regulatory actions or delays or government regulation generally; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry and general public pricing pressures; unexpected manufacturing issues; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated
'/>"/>

SOURCE Novartis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
4. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
5. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
6. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
7. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
8. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
9. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
10. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
11. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... Research and Markets ( http://www.researchandmarkets.com/research/p37spr/north_america ) has announced the ... Market - Growth, Trends And Forecasts (2014 - 2019)" ... players in the industry are GE , Hitachi Medical ... Systems MRI is a powerful ... higher sensitivity and use of non-ionizing radiations. Open MRI ...
(Date:5/29/2015)... , May 29, 2015  The annual customer satisfaction ... ranks Praxis EMR as #1 across all specialties. Every ... Research LLC conducts a poll of EHR users and ... results.    Praxis EMR topped 348 ... 18 performance based criteria used by Black Book. In ...
(Date:5/29/2015)... 29, 2015 Research and ... of the "Surgical/Operating Microscopes Market by Application ... report to their offering.      ... market is poised to reach $806.6 million by ... CAGR of 12.3% from 2015 to 2020. , ...
Breaking Medicine Technology:North America Open System MRI Market 2014-2019 with GE, Hitachi Medical, Philips Healthcare, Siemens Healthcare and Toshiba Medical Dominating 2Praxis EMR Ranks #1 for Physician Satisfaction in Black Book's 2015 Survey of Solo and Small Practices 2Surgical/Operating Microscopes Market by Application & End User - Global Forecast to 2020 for the $806 Million Industry 2
... The Procter & Gamble Company (NYSE: PG ) ... Sustainability Expert Advisory Panel (SEAP). The new members are: ... Global Initiative Dr. Howard Frumkin – Dean, School of ... Tamminen – Former Secretary, California Environmental Protection Agency ...
... HeartSine Technologies, Inc, a world leader in personal ... to an exclusive 10 years on its popular HeartSine ® ... (PAD) for the treatment of Sudden ... growing AED. The life of its Pad-Pak ® device, ...
Cached Medicine Technology:P&G Welcomes New Members to U.S. Sustainability Expert Advisory Panel 2P&G Welcomes New Members to U.S. Sustainability Expert Advisory Panel 3HeartSine® Increases AED System Warranty to Longest in the Industry 2
(Date:5/29/2015)... 2015 Intermountain Healthcare of ... Stratus Video Interpreting for on-demand ... communication and timely care for patients with ... Stratus’ video remote interpreting (VRI) services will ... to quickly access qualified medical interpretation in ...
(Date:5/29/2015)... 2015 The print component of “Skin ... of approximately 250,000 and an estimated readership of 750,000. ... social media strategy, and across a network of top ... version of the campaign, click here. , ... Inside, the actress, model and producer details her skin ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Mediaplanet has ... “beauty of protection”. Skin Health is a cross-platform ... within the markets of New York, Los Angeles, and ... 750,000 readers. Its digital counterpart will reach a national ... To read more the Skin Health campaign and Colorescience, ...
(Date:5/29/2015)... Chicago, Ill (PRWEB) May 29, 2015 ... Care , a dozen medical pioneers recognized by a ... changed the course of cancer treatment. Honorees will be ... of Cancer Care™ Award Ceremony, held 8:30-11:00 p.m. CDT ... , The 2015 honorees are being recognized for groundbreaking ...
(Date:5/29/2015)... Healthpointe is now offering pain ... therapy, and injections , For patients throughout Southern ... back pain, Healthpointe has a team of experts ... disc protrusions and other causes of back ... of renowned surgeons are now treating osteoarthritis, spinal ...
Breaking Medicine News(10 mins):Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 3Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 4Health News:Mediaplanet Launches “Skin Health” Campaign Featuring Colorescience 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 3Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 4Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 3
... The Financial Times has,selected the Campaign for ... its seasonal charity appeal to readers. CAMFED supports ... year,s appeal raised more over 600,000 pounds Sterling ... a series of articles from,November through to mid-January ...
... Materials for Medical Devices Database, CAMBRIDGE, England ... Design today announced substantial enhancement to,the only materials ... resource, demonstrated at this week,s Materials and Processes,for ... Desert, CA,now helps designers of spinal implants research ...
... Sept. 26 BioProcessors Corporation, a,leading innovator ... development, expands its Woburn operations and,launches new ... see strong interest in our SimCell technology," ... "The,biopharmaceutical industry is accelerating its pace to ...
... effort to ... health of Medicare beneficiaries, HANOVER, Md., Sept. 26 ... in partnership with,Medicare Part D prescription drug plans (PDPs) ... prescription drug therapy for Medicare,beneficiaries. Delmarva Foundation, Medicare,s QIO ...
... Sept. 26 October is Breast Cancer Awareness,Month, ... detection is at an,all-time high, the percentage of ... the Centers for Disease Control and,Prevention. Women should ... can do to maintain their long-term breast health. ...
... Sept. 26 Ziehm,Imaging, a provider of ... manufacturer of software-driven systems for targeted,less-invasive medical ... for the integration of mobile 3D C-arms ... Ziehm Imaging and BrainLAB jointly pioneered the ...
Cached Medicine News:Health News:Financial Times Selects CAMFED International for 2007 Reader Seasonal Appeal 2Health News:Financial Times Selects CAMFED International for 2007 Reader Seasonal Appeal 3Health News:Financial Times Selects CAMFED International for 2007 Reader Seasonal Appeal 4Health News:Financial Times Selects CAMFED International for 2007 Reader Seasonal Appeal 5Health News:Design Resource Extends Support for Orthopaedic and Cardiovascular Devices 2Health News:Design Resource Extends Support for Orthopaedic and Cardiovascular Devices 3Health News:BioProcessors Launches SimCell(TM) Services to Meet Increased Customer Demand 2Health News:Delmarva Foundation Implements Medication Therapy Management Program in Maryland and DC 2Health News:Revision: Ziehm Imaging and BrainLAB Announce Partnership for Intra-Operative 3D Imaging and Computer Assisted Surgery (CAS) 2Health News:Revision: Ziehm Imaging and BrainLAB Announce Partnership for Intra-Operative 3D Imaging and Computer Assisted Surgery (CAS) 3
... oximeters available, Datex-Ohmeda s TuffSat is the ... transport, and EMS. TuffSat comes fully loaded ... index measurement) a quick, easy-to-use clinical ... perfusion at the sensor site. Now you ...
... clinical information. , ,S/5 Clinical Communications ... solutions that help you and your care ... You will have access to essential patient ... with your care team and specialists, independent ...
... safe and easy patient monitoring during MRI, ... special needs of the MRI environment. It allows ... MRI, promoting safety and flexibility., ,Though designed ... all the key benefits of the S/5 Monitoring ...
... and comprehensive solution for advanced arrhythmia ... (ARRWS) provides one compact, PC-based solution ... patients. It connects to Datex-Ohmeda Network ... up to 16 beds., ,The ...
Medicine Products: